Clinical Content
Latest Videos
Video
Osteogenesis Imperfecta (OI) Clinic at Phoenix Children's
Phoenix Children’s Osteogenesis Imperfecta (OI) Clinic is focused on preventing fractures, treating bone deformities and providing customized care for each patient.
Video
A new era in transplantation is here. Roswell Park reports a remarkable 92.6% one-year survival rate following allogeneic transplant—well above the national average—thanks to evidence-based innovations transforming patient care.
Video
ASCO26: Sara Tolaney, MD, MPH, ASCENT-03
Dana-Farber Cancer Institute's Dr. Sara Tolaney from the ASCENT-03 stud in breast cancer. The data further strengthens the case for approval of sacituzumab govitecan as first-line treatment for patients with advanced triple-negative breast cancer.
Video
ASCO26: Alicia Morgans, MD, MPH, ARACOG
Dr. Alicia Morgans of Dana-Farber Cancer Institute reported at #ASCO26 that ARACOG found darolutamide was associated with less decline in cognitive testing than enzalutamide, which may help guide treatment choice.
Video
ASCO26: Atish Choudhury, MD, PhD, A-DREAM/Alliance A032101
A-DREAM/Alliance A032101 study presented by Dana-Farber Cancer Institute's Dr. Atish Choudhury shows 41% of favorable responders to testosterone suppression plus androgen receptor pathway inhibitor remaining treatment-free with testosterone ...
Video
ASCO26: Sara Tolaney, MD, MPH, ASCENT-04
Dana-Farber Cancer Institute's Dr. Sara Tolaney presented a subgroup analysis of the ASCENT-04 study based on biomarkers. Across all subgroups, patients who received sacituzumab govitecan plus pembro as first-line therapy had longer progression-free ...
Video
2026 ASCO Prostate Cancer Highlights
The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the prostate cancer clinical updates.
Video
2026 ASCO Bladder Cancer Highlights
The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the bladder cancer clinical updates
Latest Documents
Document
Treatment Guideline: First-Line Treatment for Metastatic Triple-Negative Breast Cancer (TNBC)
The Breast Oncology Center held meetings to discuss recommendations regarding first-line treatment for patients with metastatic triple-negative breast cancer (TNBC).
Document
The use of curved linear array (CLA) and radial EUS in the lower GI tract has largely been limited to the sigmoid colon and rectum, as their oblique optics present a challenge in advancement to the right side of the colon.
Document
Treatment Guideline: Vaginal Estrogen in Patients with History of Breast Cancer
The Breast Oncology Center held meetings to discuss recommendations regarding the use of vaginal estrogen in patients with a history of breast cancer.
Latest Articles
News
Lung Cancer Care in 2026: Earlier Detection, Earlier Intervention, More Individualized Treatment
Lung cancer care is entering a more precise and increasingly proactive era. While the disease remains a leading cause of cancer mortality, earlier detection through low-dose CT screening, broader use of molecular profiling and rapid advances ...
News
It Takes a Community for a Winn Scholar to Build a Clinical Trial
“My past experiences with Teach for America in North Philadelphia were a prologue to what I am doing now,” said Austin Williams, MD, MSEd, FACS, a surgical oncologist specializing in breast cancer at Fox Chase Cancer Center and Associate ...
News
Inspiration for Patients and Peers
Meet the Fox Chase physicians and researchers bridging clinical care excellence with breakthroughs in research—bringing new ideas and new hope to peers, patients, and their families.
News
The Future of Heart Care Isn't One Doctor. It's One Team.
As cardiovascular medicine becomes increasingly specialized, multidisciplinary Disease Centers are changing how complex patients are evaluated, treated and referred.
Latest Courses
Course
In this CME, Margarita Zuley, MD, discusses how to explain the indications for diagnostic breast imaging, describe the role of contrast-enhanced mammography for patients having a diagnostic evaluation, and evaluate the role of contrast-enhanced biopsy.
Course
Hereditary Hemorrhagic Telangiectasia: A Multidisciplinary Approach to Care
In this CME, Quyen Nguyen, MD, Natasha Robin Berman MA, MS, MPH, CGC, and Adam Fish, MD, discuss how to identify the major clinical manifestations of Hereditary Hemorrhagic Telangiectasia (HHT), recognize the major causes of morbidity ...
Course
The Hypermobile Hip: Biomechanics, Diagnosis, and Treatment Decision Making: Part 2
In this CME, Shannon Dipietro, PT, DPT, CLT, Kate Jochimsen, PhD, ATC, Hiliary Jablonski, PT, DPT, Michaela Golden, PT, DPT, OCS, and Daniel Cohen, MD, discuss how to perform a clinical physical examination of the hip, design exercise ...
Course
The Hypermobile Hip: Biomechanics, Diagnosis, and Treatment Decision Making: Part 1
In this CME, Keelan Enseki, PT, ATC, Mylynda Massart, MD, Kelley Anderson, DO, Daniel Lueders, MD, Angela Garcia, MD, and Michael McClincy, MD, discuss how to describe the components of a clinical physical examination of the hip and apply ...
